2cureX AB

Headquarters: Copenhagen, Denmark

Employees: 13

CEO: Mr. Ole Thastrup VD

show_chart FSX: 2QE -5.03%

Market Cap

€5.9 Million

EUR as of July 1, 2023

US$6.4 Million

history Market Cap History

2cureX AB market capitalization over time

Evolution of 2cureX AB market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of 2cureX AB

Detailed Description

2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat test that allows the physician to identify a medical treatment that is effective for a particular cancer patient. IndiTreat establishes thousands of 3D micro-tumors that are similar to the patient's tumor and identifies the treatment that kills the patient's tumor. The company is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. 2cureX AB has clinical partnerships with Skåne University Hospital in Sweden; and University Medical Center Hamburg-Eppendorf. The company was incorporated in 2006 and is based in Copenhagen, Denmark.


Unlock the Power of Financial AI:

Try Disfold AI Free for 7 Days!

Stocks & Indices

2cureX AB has the following listings and related stock indices.

Stock: FSX: 2QE wb_incandescent

Stock: OMX: 2CUREX wb_incandescent




Fruebjergvej 3

Copenhagen, 2100


Phone: 45 22 11 53 99